Sun Pharmaceutical Industries Limited at its board meeting held on May 22, 2024, recommended final dividend of INR 5 per equity share of INR 1 each for the financial year 2023-2024 to the shareholders for their approval at the upcoming Annual General Meeting of the Company. Final dividend, once approved by the shareholders, shall be to be paid within the prescribed timeline under the Companies Act, 2013.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,516 INR | +0.34% | +0.61% | +20.37% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.37% | 43.54B | |
+18.30% | 21.78B | |
+17.85% | 15.38B | |
+25.55% | 15.12B | |
+60.99% | 13.36B | |
-0.05% | 6.79B | |
-14.84% | 6.38B | |
-8.87% | 5.73B | |
+8.17% | 5.32B | |
+26.36% | 4.58B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Limited Recommends Final Dividend for the Financial Year 2023-2024